Skip to content

Nuvalent, Inc. NUVL Total Current Assets

Total Current Assets at other companies

Pfizer logo
PfizerPFE
$42.82B-6.6%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$452.95M+315%
Summit Therapeutics logo
Summit TherapeuticsSMMT
$616.6M+66.3%
Exelixis logo
ExelixisEXEL
$1.21B-13.5%
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
$1.97B-7.8%
Incyte logo
IncyteINCY
$5.48B+56.4%

Other financials

Income statement

See full
Operating income-$119.4M-25.9%
Net income-$109.3M-29.2%
EPS (diluted)-$1.39-17.8%

Balance sheet

See full
Cash & equivalents$159.7M+32.2%
Total equity$1.2B+16.2%
Total assets$1.3B+20.4%

Cash flow

See full
Operating cash flow-$92.4M-68.5%

Valuation

See full
Market cap$9.77B+58.6%

Returns & leverage

See full
Return on equity-41.2%+7.5pp
Current ratio16.1×+1.7×

Where this comes from

Reported directly by Nuvalent, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The official record: Nuvalent, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvalent, Inc.'s total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvalent, Inc.'s total current assets?
Nuvalent, Inc. (NUVL) reported total current assets of $1.31B in Q1 2026.
How has Nuvalent, Inc.'s total current assets changed year-over-year?
Nuvalent, Inc.'s total current assets increased by 20.4% year-over-year, from $1.09B to $1.31B.
What is the long-term trend for Nuvalent, Inc.'s total current assets?
Over 5 years (2020 to 2025), Nuvalent, Inc.'s total current assets has grown at a 165.0% compound annual growth rate (CAGR), from $10.65M to $1.39B.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.